Garrett Leslie A, Garner Elizabeth I O, Feltmate Colleen M, Goldstein Donald P, Berkowitz Ross S
New England Trophoblastic Disease Center, Boston, MA, USA.
J Reprod Med. 2008 Jul;53(7):481-6.
To evaluate the subsequent reproductive outcomes in patients with complete and partial molar pregnancy and gestational trophoblastic neoplasia (GTN) at the New England trophoblastic Disease Center between June 1, 1965, and December 31, 2007.
Questionnaires regarding subsequent pregnancies were mailed to all patients with current mailing addresses at the New England Trophoblastic Disease Center.
The subsequent reproductive outcomes in patients with complete and partial molar pregnancies and persistent GTN were in general the same as those in the general population. However, after an episode of molar pregnancy the incidence of molar pregnancy in a later gestation was approximately 1%. Additionally, after successful chemotherapy for GTN, the incidence of stillbirth was 1.4% in later pregnancies.
Patients with molar pregnancies and GTN should be reassured that they can in general expect a normal future reproductive outcome.
评估1965年6月1日至2007年12月31日期间在新英格兰滋养细胞疾病中心诊断为完全性和部分性葡萄胎及妊娠滋养细胞肿瘤(GTN)患者的后续生殖结局。
向新英格兰滋养细胞疾病中心所有有当前邮寄地址的患者邮寄了关于后续妊娠情况的调查问卷。
完全性和部分性葡萄胎及持续性GTN患者的后续生殖结局总体上与普通人群相同。然而,在一次葡萄胎妊娠后,后续妊娠中葡萄胎妊娠的发生率约为1%。此外,GTN化疗成功后,后续妊娠中死产的发生率为1.4%。
葡萄胎妊娠和GTN患者应放心,总体而言,他们未来的生殖结局有望正常。